Table 2. Summarized ORs or SMD in this meta-analysis.
| Group | Study | Sample size (eye) | OR | 95% CI | P | I2 (%) | Statistical model | ||
|---|---|---|---|---|---|---|---|---|---|
| Main outcomes | Recurrence rate | 23 | 1680 | 0.348 | (0.239~0.506) | < 0.001* | 0.00 | Fixed-effects model | |
| Complication rate | 17 | 1234 | 1.121 | (0.540~2.326) | 0.759 | 49.00 | Random-effects model | ||
| Surgery time | 17 | 991 | −4.142a | (−5.060~-3.224) | < 0.001* | 95.50 | Random-effects model | ||
| Recurrence rate/ Complication rate |
Region | Asia | 16/12 | 934/604 | 0.311/1.257 | (0.173~0.559)/(0.417~3.786 ) | < 0.001*/0.684 | 0/57.9 | Fixed/Random |
| non-Asia | 7/5 | 746/630 | 0.38/0.822 | (0.233~0.619)/(0.366-1.849) | < 0.001*/0.636 | 0/20.8 | Fixed/Random | ||
| Study type | RCT | 15/10 | 915/543 | 0.344/1.088 | (0.205~0.578)/(0.385~3.072) | < 0.001*/0.874 | 0/45.6 | Fixed/Random | |
| non-RCT | 8/7 | 765/691 | 0.351/1.270 | (0.204~0.604)/(0.385~4.187) | < 0.001*/0.695 | 0/60.5 | Fixed/Random | ||
| Suture material | Vicryl | 15/11 | 1299/650 | 0.351/2.561 | (0.235~0.525)/(0.556~11.791) | < 0.001*/0.227 | 0/70.5 | Fixed/Random | |
| Nylon | 8/6 | 381/584 | 0.326/0.642 | (0.115~0.920)/(0.316~1.305) | 0.034*/0.221 | 0/11.2 | Fixed/Random | ||
| Sample size | > 50 eyes | 11/7 | 1227/384 | 0.403/2.492 | (0.180~0.903)/(0.581~10.695) | 0.027*/0.059 | 0/51.5 | Fixed/Random | |
| ≤ 50 eyes | 12/10 | 453/854 | 0.333/0.602 | (0.218~0.508)/(0.356~1.019 ) | < 0.001*/0.219 | 0/0 | Fixed/Random | ||
| Follow-up | > 6 months | 11/6 | 628/365 | 0.349/0.49 | (0.199~0.612)/(0.25~0.98) | < 0.001*/0.043 | 0/0 | Fixed/Random | |
| ≤ 6 months | 12/11 | 1052/869 | 0.346/2.61 | (0.209~0.573)/(0.80~8.48) | < 0.001*/0.027 | 0/57.9 | Fixed/Random | ||
| Quality score | ≥ 3 scores | 9/6 | 576/349 | 0.353/0.426 | (0.195~0.641)/(0.178~1.018) | 0.001*/0.055 | 0/0 | Fixed/Random | |
| ≤ 2 scores | 6/4 | 339/194 | 0.319/3.987 | (0.111~0.916)/(1.297~12.255) | 0.034*/0.016* | 0/0 | Fixed/Random | ||
| Complication | Hemorrhage | 3 | 132 | 1.575 | (0.532~4.658) | 0.412 | 0.00 | Fixed-effects model | |
| Dehiscence | 9 | 755 | 1.068 | (0.524~2.177) | 0.857 | 0.00 | Fixed-effects model | ||
| Inflammation | 9 | 801 | 1.102 | (0.716~1.696) | 0.658 | 33.60 | Fixed-effects model | ||
| Corneal lesions | 3 | 537 | 0.543 | (0.243~1.211) | 0.136 | 0.00 | Fixed-effects model | ||
| Retraction | 4 | 199 | 6.398 | (1.629~25.125) | 0.008* | 0.00 | Fixed-effects model | ||
*: statistical significance.
a:SMD.